Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study
ConclusionsIn our cohort, the risk of EC inBRCA1/2 carriers after RRSO is not greater than expected. Hysterectomy is not routinely recommended for these patients.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Endometrial Cancer | Hysterectomy | Spain Health | Study | Women